160 related articles for article (PubMed ID: 32031089)
1. Oral health related qualıty of lıfe and dısease severıty ın autoımmune bullous dıseases.
Bilgic A; Aydin F; Sumer P; Keskiner I; Koc S; Bozkurt S; Mumcu G; Alpsoy E; Uzun S; Akman-Karakas A
Niger J Clin Pract; 2020 Feb; 23(2):159-164. PubMed ID: 32031089
[TBL] [Abstract][Full Text] [Related]
2. Measuring of quality of life in autoimmune blistering disorders in Poland. Validation of disease - specific Autoimmune Bullous Disease Quality of Life (ABQOL) and the Treatment Autoimmune Bullous Disease Quality of Life (TABQOL) questionnaires.
Kalinska-Bienias A; Jakubowska B; Kowalewski C; Murrell DF; Wozniak K
Adv Med Sci; 2017 Mar; 62(1):92-96. PubMed ID: 28208086
[TBL] [Abstract][Full Text] [Related]
3. The effect of autoimmune blistering diseases on work productivity.
Wang EQ; Radjenovic M; Castrillón MA; Feng GHY; Murrell DF
J Eur Acad Dermatol Venereol; 2018 Nov; 32(11):1959-1966. PubMed ID: 29730897
[TBL] [Abstract][Full Text] [Related]
4. Pemphigus disease activity measurements: pemphigus disease area index, autoimmune bullous skin disorder intensity score, and pemphigus vulgaris activity score.
Rahbar Z; Daneshpazhooh M; Mirshams-Shahshahani M; Esmaili N; Heidari K; Aghazadeh N; Hejazi P; Ghajarzadeh M; Chams-Davatchi C
JAMA Dermatol; 2014 Mar; 150(3):266-72. PubMed ID: 24429657
[TBL] [Abstract][Full Text] [Related]
5. Quality of life index in autoimmune bullous dermatosis patients.
Penha MÁ; Farat JG; Miot HA; Barraviera SR
An Bras Dermatol; 2015; 90(2):190-4. PubMed ID: 25830988
[TBL] [Abstract][Full Text] [Related]
6. Reliability of the autoimmune bullous disease quality of life (ABQOL) questionnaire in the USA.
Sebaratnam DF; Okawa J; Payne A; Murrell DF; Werth VP
Qual Life Res; 2015 Sep; 24(9):2257-60. PubMed ID: 25795375
[TBL] [Abstract][Full Text] [Related]
7. Loss of Work Productivity and Quality of Life in Patients With Autoimmune Bullous Dermatoses.
Heelan K; Hitzig SL; Knowles S; Drucker AM; Mittmann N; Walsh S; Shear NH
J Cutan Med Surg; 2015; 19(6):546-54. PubMed ID: 25888597
[TBL] [Abstract][Full Text] [Related]
8. Outcome measures for autoimmune blistering diseases.
Zhao CY; Murrell DF
J Dermatol; 2015 Jan; 42(1):31-6. PubMed ID: 25558950
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the quality of life of Egyptian and Tunisian autoimmune bullous diseases' patients using an Arabic version of the autoimmune bullous disease quality of life and the treatment of autoimmune bullous disease quality of life questionnaires.
Saleh MA; Zaraa I; Doss N; Saleh NA; Murrell DF
An Bras Dermatol; 2019; 94(4):399-404. PubMed ID: 31644610
[TBL] [Abstract][Full Text] [Related]
10. Development of a quality-of-life instrument for autoimmune bullous disease: the Autoimmune Bullous Disease Quality of Life questionnaire.
Sebaratnam DF; Hanna AM; Chee SN; Frew JW; Venugopal SS; Daniel BS; Martin LK; Rhodes LM; Tan JC; Wang CQ; Welsh B; Nijsten T; Murrell DF
JAMA Dermatol; 2013 Oct; 149(10):1186-91. PubMed ID: 23925444
[TBL] [Abstract][Full Text] [Related]
11. Skin-Related Quality of Life During Autoimmune Bullous Disease Course.
Hopkins ZH; Jimenez A; Taliercio VL; Clarke JT; Hansen CB; Hull CM; Rhoads JLW; Zone JJ; Sahni VN; Kean J; Secrest AM
JAMA Dermatol; 2023 Nov; 159(11):1185-1194. PubMed ID: 37703003
[TBL] [Abstract][Full Text] [Related]
12. Estimated cut-off values for pemphigus severity classification according to pemphigus disease area index (PDAI), autoimmune bullous skin disorder intensity score (ABSIS), and anti-desmoglein 1 autoantibodies.
Mohebi F; Tavakolpour S; Teimourpour A; Toosi R; Mahmoudi H; Balighi K; Ghandi N; Ghiasi M; Nourmohammadpour P; Lajevardi V; Abedini R; Azizpour A; Nasimi M; Daneshpazhooh M
BMC Dermatol; 2020 Oct; 20(1):13. PubMed ID: 33129291
[TBL] [Abstract][Full Text] [Related]
13. The development and validation of the treatment of autoimmune bullous disease quality of life questionnaire, a tool to measure the quality of life impacts of treatments used in patients with autoimmune blistering disease.
Tjokrowidjaja A; Daniel BS; Frew JW; Sebaratnam DF; Hanna AM; Chee S; Dermawan A; Wang CQ; Lim C; Venugopal SS; Rhodes LM; Welsh B; Nijsten T; Murrell DF
Br J Dermatol; 2013 Nov; 169(5):1000-6. PubMed ID: 24102329
[TBL] [Abstract][Full Text] [Related]
14. Chinese version of the treatment of autoimmune bullous disease quality of life questionnaire: Reliability and validity.
Chen G; Yang B; Zhang Z; Yang Q; Yan X; Murrell DF; Zhang F
Indian J Dermatol Venereol Leprol; 2018; 84(4):431-436. PubMed ID: 28485307
[TBL] [Abstract][Full Text] [Related]
15. Quality of Life in Greek Patients with Autoimmune Bullous Diseases Assessed with ABQOL and TABQOL Indexes.
Patsatsi A; Kokolios M; Kyriakou A; Lamprou F; Stylianidou D; Tsapas A; Goulis DG; Murrell DF; Sotiriadis D
Acta Derm Venereol; 2017 Oct; 97(9):1145-1147. PubMed ID: 28660281
[TBL] [Abstract][Full Text] [Related]
16. Coexistence of autoimmune bullous diseases (AIBDs) and psoriasis: A series of 145 cases.
Ohata C; Ishii N; Koga H; Fukuda S; Tateishi C; Tsuruta D; Furumura M; Hashimoto T
J Am Acad Dermatol; 2015 Jul; 73(1):50-5. PubMed ID: 25896671
[TBL] [Abstract][Full Text] [Related]
17. Oral Health-Related Quality of Life and Periodontal Status of Pregnant Women.
Geevarghese A; Baskaradoss JK; Sarma PS
Matern Child Health J; 2017 Aug; 21(8):1634-1642. PubMed ID: 28155025
[TBL] [Abstract][Full Text] [Related]
18. The severity of facial burns, dental caries, periodontal disease, and oral hygiene impact oral health-related quality of life of burns victims in Pakistan: a cross-sectional study.
Chaudhary FA; Ahmad B; Sinor MZ
BMC Oral Health; 2021 Nov; 21(1):570. PubMed ID: 34749722
[TBL] [Abstract][Full Text] [Related]
19. Spectrum of Autoimmune Bullous Diseases in Northern Greece. A 4-year Retrospective Study and Review of the Literature.
Patsatsi A; Lamprou F; Kokolios M; Stylianidou D; Trigoni A; Kalampalikis D; Sotiriadis D
Acta Dermatovenerol Croat; 2017 Oct; 25(3):195-201. PubMed ID: 29252171
[TBL] [Abstract][Full Text] [Related]
20. Assessing quality of life in patients with autoimmune bullous diseases using the Persian version of Treatment of Autoimmune Bullous Disease Quality of Life questionnaire finds similar effects in women as men.
Behkar A; Garmaroudi G; Nasimi M; Yousefi S; Khosravi H; Kianfar N; Murrell DF; Daneshpazhooh M
Int J Womens Dermatol; 2022 Mar; 8(1):e004. PubMed ID: 35620025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
